Long-Acting Insulin Analogs and the Risk of Diabetic Ketoacidosis in Children and Adolescents With Type 1 Diabetes

@inproceedings{Karges2010LongActingIA,
  title={Long-Acting Insulin Analogs and the Risk of Diabetic Ketoacidosis in Children and Adolescents With Type 1 Diabetes},
  author={Beate Karges and T M Kapellen and Andreas Neu and Sabine E Hofer and Tilman Robert Rohrer and Joachim Rosenbauer and Johannes Wolf and Reinhard W. Holl},
  booktitle={Diabetes care},
  year={2010}
}
OBJECTIVE To investigate if long-acting insulin analogs decrease the risk of diabetic ketoacidosis (DKA) in young individuals with type 1 diabetes. RESEARCH DESIGN AND METHODS Of 48,110 type 1 diabetic patients prospectively studied between 2001 and 2008, the incidence of DKA requiring hospitalization was analyzed in 10,682 individuals aged </=20 years with… CONTINUE READING